FDA revives MCA's suspended eateries

The Maharashtra Food and Drug Administration (FDA) announced on Saturday that it will reverse its decision to suspend the licenses of five restaurants located in the Mumbai Cricket Association (MCA) premises. This move comes after the Bombay High Court intervened, expressing dissatisfaction with the FDA's seemingly overly strict and literal approach to the situation. The court had previously warned the authorities against taking a pedantic stance and urged them to consider a more practical perspective.

The five eateries, situated in the Bandra-Kurla Complex (BKC) area, had been suspended on August 21 following an initial inspection that raised concerns over poor refrigeration, unhygienic food handling and storage, inadequate temperature control, and sanitation lapses. However, upon a fresh inspection conducted on August 25, the FDA reported that the establishments were 88 percent compliant with food safety regulations.

The Bombay High Court, in a significant ruling, vacated the suspension order, stating that there is no legal prohibition on the eateries resuming operations. The court also hinted at issuing contempt action against the concerned FDA officials for their perceived rigid interpretation of the situation. The bench emphasized the need for a more balanced and pragmatic approach, cautioning against harsh penalties that could discourage regulatory officers.

The five affected restaurants - Permit Room, Pavilion, Mediterranean, Oriental Swing, and Clubway & Pastry Counter - are all located within MCA's Sharad Pawar Indoor Cricket Academy premises. The initial warning from the FDA centered around issues such as subpar refrigeration, unhygienic food handling and storage practices, inadequate temperature control, and sanitation lapses.

This development is part of an ongoing enforcement push by the Maharashtra FDA, which recently inspected 45 hotels, restaurants, eateries, and dhabas, conducted 25 raids, and issued improvement notices to 33 establishments. Although 11 food establishments had their licenses suspended during this drive, the FDA's latest decision marks a significant shift in their approach towards compliance and rectification of operational lapses.